102 related articles for article (PubMed ID: 28684164)
41. Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8+ T cells by preventing terminal effector differentiation.
Muraoka D; Seo N; Hayashi T; Hyuga-Amaike C; Okamori K; Tawara I; Harada N; Shiku H
Oncotarget; 2017 May; 8(19):30766-30780. PubMed ID: 28430604
[TBL] [Abstract][Full Text] [Related]
42. COVID-19 imparted immune manifestation can be combated by NLGP: Lessons from cancer research.
Bose A; Baral R
Cytokine; 2022 Oct; 158():155980. PubMed ID: 35921791
[TBL] [Abstract][Full Text] [Related]
43. Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction.
André MC; Sigurdardottir D; Kuttruff S; Pömmerl B; Handgretinger R; Rammensee HG; Steinle A
Int J Cancer; 2012 Oct; 131(7):1601-10. PubMed ID: 21607945
[TBL] [Abstract][Full Text] [Related]
44. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
45. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.
Schuberth PC; Jakka G; Jensen SM; Wadle A; Gautschi F; Haley D; Haile S; Mischo A; Held G; Thiel M; Tinguely M; Bifulco CB; Fox BA; Renner C; Petrausch U
Gene Ther; 2013 Apr; 20(4):386-95. PubMed ID: 22739387
[TBL] [Abstract][Full Text] [Related]
46. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
47. Glycolysis inhibition induces anti-tumor central memory CD8
Tang X; Mao X; Ling P; Yu M; Pan H; Wang J; Liu M; Pan H; Qiu W; Che N; Zhang K; Bao F; Peng H; Ding Q; Wang S; Zhou W
Nat Commun; 2024 May; 15(1):4665. PubMed ID: 38821965
[TBL] [Abstract][Full Text] [Related]
48. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells.
Gattinoni L; Zhong XS; Palmer DC; Ji Y; Hinrichs CS; Yu Z; Wrzesinski C; Boni A; Cassard L; Garvin LM; Paulos CM; Muranski P; Restifo NP
Nat Med; 2009 Jul; 15(7):808-13. PubMed ID: 19525962
[TBL] [Abstract][Full Text] [Related]
49. Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype.
Neeson P; Shin A; Tainton KM; Guru P; Prince HM; Harrison SJ; Peinert S; Smyth MJ; Trapani JA; Kershaw MH; Darcy PK; Ritchie DS
Gene Ther; 2010 Sep; 17(9):1105-16. PubMed ID: 20428216
[TBL] [Abstract][Full Text] [Related]
50. Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.
Moogk D; Zhong S; Yu Z; Liadi I; Rittase W; Fang V; Dougherty J; Perez-Garcia A; Osman I; Zhu C; Varadarajan N; Restifo NP; Frey AB; Krogsgaard M
J Immunol; 2016 Jul; 197(2):644-54. PubMed ID: 27271569
[TBL] [Abstract][Full Text] [Related]
51. NLGP regulates RGS5-TGFβ axis to promote pericyte-dependent vascular normalization during restricted tumor growth.
Dasgupta S; Saha A; Ganguly N; Bhuniya A; Dhar S; Guha I; Ghosh T; Sarkar A; Ghosh S; Roy K; Das T; Banerjee S; Pal C; Baral R; Bose A
FASEB J; 2022 May; 36(5):e22268. PubMed ID: 35363396
[TBL] [Abstract][Full Text] [Related]
52. Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7.
Unsoeld H; Pircher H
J Virol; 2005 Apr; 79(7):4510-3. PubMed ID: 15767451
[TBL] [Abstract][Full Text] [Related]
53. Neem Leaf Glycoprotein disrupts exhausted CD8+ T cell-mediated cancer stem cell aggression.
Chakravarti M; Bera S; Dhar S; Sarkar A; Choudhury PR; Ganguly N; Das J; Sultana J; Guha A; Biswas S; Das T; Hajra S; Banerjee S; Baral R; Bose A
Mol Cancer Res; 2024 May; ():. PubMed ID: 38743057
[TBL] [Abstract][Full Text] [Related]
54. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
Tang VA; Rosenthal KL
J Reprod Immunol; 2010 Dec; 87(1-2):39-44. PubMed ID: 20688399
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines.
Daudt L; Maccario R; Locatelli F; Turin I; Silla L; Montini E; Percivalle E; Giugliani R; Avanzini MA; Moretta A; Montagna D
J Immunother; 2008 May; 31(4):385-93. PubMed ID: 18391757
[TBL] [Abstract][Full Text] [Related]
56. Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow.
Biasi G; Facchinetti A; Cappellari R; Rossi E; Zanovello P
Immunol Lett; 2011 Jul; 138(1):79-85. PubMed ID: 21453727
[TBL] [Abstract][Full Text] [Related]
57. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
58. IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells.
Schenkel JM; Fraser KA; Casey KA; Beura LK; Pauken KE; Vezys V; Masopust D
J Immunol; 2016 May; 196(9):3920-6. PubMed ID: 27001957
[TBL] [Abstract][Full Text] [Related]
59. IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.
Desbois M; Le Vu P; Coutzac C; Marcheteau E; Béal C; Terme M; Gey A; Morisseau S; Teppaz G; Boselli L; Jacques Y; Béchard D; Tartour E; Cassard L; Chaput N
J Immunol; 2016 Jul; 197(1):168-78. PubMed ID: 27217584
[TBL] [Abstract][Full Text] [Related]
60. Prophylactic dose of neem (Azadirachta indica) leaf preparation restricting murine tumor growth is nontoxic, hematostimulatory and immunostimulatory.
Haque E; Mandal I; Pal S; Baral R
Immunopharmacol Immunotoxicol; 2006; 28(1):33-50. PubMed ID: 16684666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
